Prevention of neurologic disability associated with preterm birth is one of the major challenges
in current perinatal medicine. Magnesium sulfate (MgSO 4 ), the focus of this review has …

Objective: This study aims to analyze the effect of advanced maternal age (> 35 years old) in
maternal and perinatal outcomes of preeclampsia women. Materials and methods: This is a …

Objectives Data on the clinical manifestations and pregnancy outcomes of pregnant women
with COVID-19 are limited, particularly in developing countries. The aim of this study was to …

Objective Our objective was to determine if treatment with pravastatin prevents preeclampsia
in pregnant patients at risk of preeclampsia. Material and Methods The study was …

Objectives Chronic hypertension in pregnancy is an important cause of maternal and neonatal
morbidity and mortality. The aim of this study was to determine the effect of severity of …

Objectives: to determine which of the ris factors above associated with the occurrence of
severe preeclampsia at dr. Soetomo Hospital, Surabaya during 2015. Materials and Methods: …

Objectives This study aimed to evaluate the effect of pravastatin to prevent preeclampsia (PE)
in pregnant women at a high risk of developing PE and the maternal and perinatal …

Objectives. This study is aimed at evaluating the maternal and perinatal characteristics and
pregnancy outcomes of ES. Material and Methods. This is a retrospective cohort study of …

Objectives To evaluate maternal hypertension, risk of cardiovascular disease (CVD), and
metabolic syndrome five years after delivery in preterm preeclampsia (P-PE), term …

COVID-19 pandemic has been lasting for years, and pregnant women encounter an increased
risk of mortality and morbidity. Until now, vaccine COVID-19 has been developed and …